Akomera Overview
- Year Founded
-
2026
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Akomera General Information
Description
Developer of a non-pharmacological hearing preservation technology designed to protect patients from treatment-related hearing loss before permanent damage occurs. The company offers a drug-free, wearable hearing protection technology designed to integrate seamlessly into existing oncology care protocols, enabling cancer patients undergoing platinum-based chemotherapy to proactively preserve their hearing and overall quality of life without interfering with their treatment.
Contact Information
Website
www.akomera.comCorporate Office
- Houston, TX
- United States
Corporate Office
- Houston, TX
- United States
Akomera Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Nov-2026 | Completed | Pre-Clinical Trials |
Akomera Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Texas Medical Center | Venture Capital | Minority |
Akomera FAQs
-
When was Akomera founded?
Akomera was founded in 2026.
-
Where is Akomera headquartered?
Akomera is headquartered in Houston, TX.
-
What industry is Akomera in?
Akomera’s primary industry is Therapeutic Devices.
-
Is Akomera a private or public company?
Akomera is a Private company.
-
What is Akomera’s current revenue?
The current revenue for Akomera is .
-
Who are Akomera’s investors?
Texas Medical Center has invested in Akomera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process